biological-nitrogen
(2)
Bill Brady and the price of a good idea
After 23 years at Cabot, Bill Brady took his factory-floor education into climate startups. At Kula Bio, the founding CEO turned Executive Chairman has kept returning to a stubborn question: will the customer buy it?
Chris Abbott
Chris Abbott is the Chief Executive Officer of Pivot Bio, a Berkeley-based agricultural biotechnology company pioneering microbial nitrogen solutions that replace synthetic fertilizers. A Minnesota native and University of Minnesota graduate, Abbott built his career at the intersection of agriculture finance and agtech investing - from Wall Street sell-side research at Piper Jaffray to co-leading Continental Grain's Conti Ventures. He joined Pivot Bio's board in 2018, and in August 2023 stepped up as CEO, guiding the company past $100 million in annual revenue while scaling its gene-edited microbes to over 5 million acres. Under his leadership, Pivot Bio achieved 60% year-over-year revenue growth and has helped farmers reduce synthetic nitrogen use by over 129,000 metric tons.